Historical record - last NADAC effective date: 8/23/2023
Product Information
CELECOXIB 100 MG CAPSULE is a generic product labeled by Yiling Pharmaceutical Inc., priced at $0.0965 per EA under NDC 69117002103. Its NADAC has been published 57 times since Jul 27, 2022.
FDA first approved this application on Mar 6, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Yiling Pharmaceutical Inc.NDC
69117002103
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/23/2023
Active Ingredients
CELECOXIBApproval Type
Generic (ANDA)
FDA Application
ANDA211412FDA Approved
3/6/2020
TE Code
AB
On Market Since
3/6/2020
Pharmacological Classes
Price Statistics
The NADAC for CELECOXIB 100 MG CAPSULE has been published 57 times since Jul 27, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0965 per EA |
|---|---|
| All-time high | $0.1182 (Oct 12, 2022) |
| All-time low | $0.0905 (Mar 22, 2023) |
| Median price | $0.0995 |
| Average price | $0.1006 |
| Largest weekly change | +11.6% (Sep 21, 2022) |
| Weeks tracked | 57 |
| Tracking since | Jul 27, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+3.9%
5Y
N/A
All
-2.0%
Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 16 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CELECOXIB 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 100 MG CAPSULE, manufactured by Yiling Pharmaceutical Inc., is $0.0965 per EA (NDC 69117002103), effective Aug 23, 2023.
How has the price of CELECOXIB 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELECOXIB 100 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 57 weekly CMS publications since Jul 27, 2022.
What are the highest and lowest recorded NADAC prices for CELECOXIB 100 MG CAPSULE?
Since Jul 27, 2022, the NADAC for CELECOXIB 100 MG CAPSULE has ranged from a low of $0.0905 (Mar 22, 2023) to a high of $0.1182 (Oct 12, 2022), with a median of $0.0995 per EA.
Are there cheaper alternatives to CELECOXIB 100 MG CAPSULE?
Yes. 16 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CELECOXIB 100 MG CAPSULE, is $0.0621 per EA — about 36% below CELECOXIB 100 MG CAPSULE.
Who manufactures CELECOXIB 100 MG CAPSULE?
CELECOXIB 100 MG CAPSULE (NDC 69117002103) is labeled by Yiling Pharmaceutical Inc., and CMS classifies it as a generic product.